GoHealth (GOCO): Distribution-first Medicare marketplace with concentrated, contract-driven revenue

GoHealth operates a digital marketplace and services platform that sells and administers Medicare insurance products on behalf of large health plans; the company monetizes primarily through commissions and fees paid by those health plan partners for enrollment and engagement services, and its economics are tightly coupled to a small number of large payors. For investors, the story is one of a high-margin distribution and services engine whose growth and downside are driven by partner contracting dynamics, concentration with top plans, and U.S.-only exposure. Learn more about how we map these counterparty relationships at https://nullexposure.com/.

How GoHealth makes money and how the commercial model is structured

GoHealth’s revenue model is straightforward: the company sells Medicare products for health plans through digital and call-center channels and collects commissions and fees from the plans that buy that distribution. The 2024 10‑K describes the firm’s core services as sale and administration of Medicare offerings through both an agency and a non‑agency Encompass operating model, which underpins recurring revenue tied to enrollment and engagement performance. The filing explicitly states that the health plan partners are the customers responsible for paying those commissions and fees.

This is a contractual business: GoHealth maintains formal relationships with payors and operates as a vendor/agent of distribution rather than as an insurer, creating a commercial posture where contract terms, performance metrics, and plan sales mix drive revenue volatility and negotiating leverage.

The five plan relationships GoHealth discloses (what they mean for investors)

United

United is listed among GoHealth’s primary health plan partners for the 2022–2024 period in the company’s FY2024 10‑K, indicating an active contractual channel relationship for Medicare product distribution. According to the FY2024 10‑K, United is one of the top health plans GoHealth served for the twelve months ended December 31, 2024. (Source: GoHealth FY2024 10‑K)

Humana

Humana is identified as a primary health plan partner across 2022–2024 and is included in the same disclosure of principal partners, reflecting an ongoing buyer relationship that contributes commissions and fees to GoHealth’s revenue base. The FY2024 10‑K lists Humana among the company’s primary plan partners for those periods. (Source: GoHealth FY2024 10‑K)

Elevance

Elevance (formerly Anthem/Blue Cross Blue Shield enterprise) is also named among GoHealth’s primary plan partners in the FY2024 10‑K, confirming that GoHealth’s Medicare distribution work includes several of the largest national payors. The 10‑K identifies Elevance as one of the principal partners served in the 2022–2024 timeframe. (Source: GoHealth FY2024 10‑K)

Aetna

Aetna appears on GoHealth’s list of primary health plan partners for 2022–2024, showing that Aetna is part of the company’s core buyer set that pays for enrollment and engagement services. The FY2024 10‑K includes Aetna among the primary plans the company served for the twelve months ended December 31, 2024. (Source: GoHealth FY2024 10‑K)

Centene

Centene is likewise disclosed as a primary plan partner across the 2022–2024 period, underscoring GoHealth’s exposure to both national and government‑focused payors. The FY2024 10‑K lists Centene among the primary health plan partners served in those years. (Source: GoHealth FY2024 10‑K)

What the disclosures imply about GoHealth’s operating constraints and risk profile

GoHealth’s public filing and the relationship set drive several company‑level signals that investors must weigh:

• Geographic concentration: The company states that it derives substantially all of its revenues from customers located in the United States, making GoHealth strictly exposed to U.S. Medicare dynamics and regulatory changes. (Source: FY2024 10‑K evidence excerpts)
• Concentration risk and materiality: The filing presents a table of health plan partners representing 10% or more of total revenue for certain periods, signaling material revenue concentration among a small number of plan customers and elevated counterparty risk if contract economics shift. (Source: FY2024 10‑K evidence excerpts)
• Buyer relationship posture: GoHealth’s partners are described explicitly as customers who pay commissions and fees for enrollment and engagement services, which means GoHealth is contractually dependent on those buyers’ procurement decisions and payment terms rather than captive internal demand. (Source: FY2024 10‑K evidence excerpts)
• Active, service‑based engagement: The primary services relate to sale and administration of Medicare products, and the company operates using defined agency and non‑agency models, indicating operational maturity of its commercial offerings and an ongoing service delivery obligation that can affect margin if scale or performance shifts. (Source: FY2024 10‑K evidence excerpts)

For practical investors, these constraints translate into two central themes: distribution leverage (ability to scale enrollments through partner agreements) and counterparty risk (revenue dependency on a handful of large plans).

If you want a deeper counterparty map showing plan-level exposure and contract maturity trends, visit https://nullexposure.com/ for our expanded analysis and tracking tools.

Investment implications and risk factors to watch

• Concentration of revenue: A small set of large payors drives a meaningful portion of revenue; plan contract renewals, commission rate resets, or changes in plan distribution strategy are direct drivers of GoHealth’s top line. This is the primary operational lever for upside and downside.
• Regulatory and Medicare policy risk: Because GoHealth’s core product is Medicare distribution, federal policy changes to Medicare Advantage reimbursement or enrollment rules will materially affect the company’s addressable market and unit economics.
• Operational execution: GoHealth’s business is as much about technology and customer acquisition as it is about compliance and call‑center performance; slippage in enrollment conversion or partner satisfaction can compress fees or trigger contract renegotiation.
• U.S. market exposure: Substantial all‑U.S. revenue means macro and demographic trends in the U.S. healthcare market are directly consequential.

These factors make GoHealth a distribution play with high operational leverage: successful scaling of partner relationships expands revenue rapidly, but concentrated counterparties create asymmetric downside if key plans change their channels.

Final read for investors

GoHealth is a specialized distribution and services company centered on Medicare products, monetizing through commissions and fees paid by a small set of large health plans—United, Humana, Elevance, Aetna, and Centene—each named as a primary partner in the FY2024 10‑K. The company’s U.S.-only revenue footprint, documented materiality of plan partners, and explicit buyer-role contracting posture collectively frame an investment thesis that is growth‑oriented but counterparty‑sensitive.

For portfolio managers and operators evaluating exposure to GoHealth’s counterparty network, prioritize monitoring contract renewals, commission rate disclosures, and any plan-level shifts in distribution strategy. For comprehensive counterparty intelligence and ongoing tracking, see our coverage at https://nullexposure.com/.

Bold positioning, focused risk monitoring, and active tracking of plan contracts are the practical next steps for investors allocating to GOCO.